[1]
“Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies”, Reumatismo, vol. 75, no. 4, Dec. 2023, doi: 10.4081/reumatismo.2023.1602.